Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 3

2(28.6%)

7Total

N/A(5)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07554391Completed

To Analyze the Economics of Office-based (OBS) Versus Ambulatory Surgery Center (ASC)-Based Cataract Surgery.

Role: lead

NCT04903301Not ApplicableCompleted

Patient Satisfaction With Contoura Vision Topography-Guided LASIK

Role: lead

NCT04380077Not ApplicableUnknown

Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics

Role: lead

NCT04380064Not ApplicableUnknown

Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy

Role: lead

NCT01708538Phase 3Unknown

The Effects of Corneal Collagen Cross-linking

Role: lead

NCT03660384Not ApplicableCompleted

Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy

Role: lead

NCT03660345Phase 3Completed

PPV With Internal Limiting Membrane Peeling for Treatment-Naïve DME

Role: lead

NCT03660371Not ApplicableCompleted

ILM Peeling in PDR Patients Undergoing PPV for VH

Role: lead

All 8 trials loaded